Skip to content

Clinical trials

Ovarian Neoplasms trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Country / region: Brazil Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20081
20092
20103
20112
20121
20132
20152
20161
20172
20181
20192
20205
20212
20221
20232
20242
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting11
Active, not recruiting10
Terminated5
Not yet recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca7
Merck Sharp & Dohme LLC4
AbbVie3
Daiichi Sankyo3
Hoffmann-La Roche3
Latin American Cooperative Oncology Group3
Amgen2
Recepta Biopharma2
Telik2
CanariaBio Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms43
Fallopian Tube Neoplasms16
Carcinoma, Ovarian Epithelial6
Peritoneal Neoplasms5
Breast Neoplasms4
Endometrial Neoplasms4
Neoplasms4
Recurrence3
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Transitional Cell2

Trials

Showing 26 to 43 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.